001     273914
005     20241215000106.0
024 7 _ |a 10.1016/j.jbc.2024.107835
|2 doi
024 7 _ |a pmid:39342994
|2 pmid
024 7 _ |a pmc:PMC11602988
|2 pmc
024 7 _ |a 0021-9258
|2 ISSN
024 7 _ |a 1067-8816
|2 ISSN
024 7 _ |a 1083-351X
|2 ISSN
024 7 _ |a altmetric:169630924
|2 altmetric
037 _ _ |a DZNE-2024-01388
041 _ _ |a English
082 _ _ |a 540
100 1 _ |a Wittern, Carla Isabel
|b 0
245 _ _ |a Comprehensive characterization of the OCT1 phenylalanine-244-alanine substitution reveals highly substrate-dependent effects on transporter function.
260 _ _ |a Bethesda, Md.
|c 2024
|b Soc.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1733822730_16146
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a ISSN 0021-9258 not unique: **2 hits**.
520 _ _ |a Organic cation transporters (OCTs) can transport structurally highly diverse substrates. The molecular basis of this extensive polyspecificity has been further elucidated by cryo-EM. Apparently, in addition to negatively charged amino acids, aromatic residues may contribute to substrate binding and substrate selectivity. In this study, we provide a comprehensive characterization of phenylalanine 244 in OCT1 function. We analyzed the uptake of 144 OCT1 substrates for the phenylalanine 244 to alanine substitution compared to WTOCT1. This substitution had highly substrate-specific effects ranging from transport reduced to 10% of WT activity up to 8-fold increased transport rates. Four percent of substrates showed strongly increased uptake (>200% of WT) whereas 39% showed strongly reduced transport (<50% of WT). Particularly with larger, more hydrophobic, and more aromatic substrates, the Phe244Ala substitution resulted in higher transport rates and lower inhibition of the transporter. In contrast, substrates with a lower molecular weight and less aromatic rings showed generally decreased uptake rates. A comparison of our data to available transport kinetic data demonstrates that generally, high-affinity low-capacity substrates show increased uptake by the Phe244Ala substitution, whereas low-affinity high-capacity substrates are characterized by reduced transport rates. Altogether, our study provides the first comprehensive characterization of the functional role of an aromatic amino acid within the substrate translocation pathway of OCT1. The pleiotropic function further highlights that phenylalanine 244 interacts in a highly specific manner with OCT1 substrates and inhibitors.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a alanine mutagenesis
|2 Other
650 _ 7 |a binding pocket
|2 Other
650 _ 7 |a inhibition
|2 Other
650 _ 7 |a organic cation transporter 1
|2 Other
650 _ 7 |a polyspecificity
|2 Other
650 _ 7 |a site-directed mutagenesis
|2 Other
650 _ 7 |a transport
|2 Other
650 _ 7 |a Phenylalanine
|0 47E5O17Y3R
|2 NLM Chemicals
650 _ 7 |a Alanine
|0 OF5P57N2ZX
|2 NLM Chemicals
650 _ 7 |a Organic Cation Transporter 1
|2 NLM Chemicals
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Phenylalanine: metabolism
|2 MeSH
650 _ 2 |a Phenylalanine: chemistry
|2 MeSH
650 _ 2 |a Amino Acid Substitution
|2 MeSH
650 _ 2 |a Substrate Specificity
|2 MeSH
650 _ 2 |a HEK293 Cells
|2 MeSH
650 _ 2 |a Alanine: metabolism
|2 MeSH
650 _ 2 |a Alanine: chemistry
|2 MeSH
650 _ 2 |a Kinetics
|2 MeSH
650 _ 2 |a Biological Transport
|2 MeSH
650 _ 2 |a Organic Cation Transporter 1: metabolism
|2 MeSH
650 _ 2 |a Organic Cation Transporter 1: genetics
|2 MeSH
650 _ 2 |a Organic Cation Transporter 1: chemistry
|2 MeSH
700 1 _ |a Schröder, Sophie
|0 P:(DE-2719)9001406
|b 1
|u dzne
700 1 _ |a Jensen, Ole
|b 2
700 1 _ |a Brockmöller, Jürgen
|b 3
700 1 _ |a Gebauer, Lukas
|b 4
773 _ _ |a 10.1016/j.jbc.2024.107835
|g Vol. 300, no. 11, p. 107835 -
|0 PERI:(DE-600)1474604-9
|n 11
|p 107835
|t The journal of biological chemistry
|v 300
|y 2024
|x 0021-9258
856 4 _ |u https://pub.dzne.de/record/273914/files/DZNE-2024-01388%20SUP.zip
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/273914/files/DZNE-2024-01388.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/273914/files/DZNE-2024-01388.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:273914
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)9001406
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2024
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2021-05-04
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J BIOL CHEM : 2019
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2021-05-04
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-05-04
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2021-05-04
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-05-04
920 1 _ |0 I:(DE-2719)1440015
|k Clinical Dementia Research (Göttingen)
|l Clinical Dementia Research (Göttingen)
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1440015
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21